Most experimental studies focused on EPO treatment within the first hours following vessel occlusion [7], simulating the unpredictable situation clinicians face in the emergency department or in the stroke unit after sudden onset of a neurological deficit. The gene discussed is EPO; the disease is stroke disorder.